 |
Articles: Myeloproliferative Dz |
Prior Articles
A monoclonal gammopathy precedes multiple myeloma in most patients
Blood, 02/25/09
Evidence Based Medicine
B-Lymphocyte stimulator: a new biomarker for multiple myeloma
European Journal of Haematology, 02/25/09 Karyotype complements the International Prognostic Scoring System for primary myelofibrosis
European Journal of Haematology, 02/25/09 Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
International Journal of Hematology, 02/24/09 Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
Clinical Cancer Research, 02/23/09 Advancements in the molecular pathogenesis of myelodysplastic syndrome
Current Opinion in Hematology, 02/23/09 Optimal sequencing of treatments for patients with myelodysplastic syndromes
Current Opinion in Hematology, 02/23/09 In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: Are they laboratory artefacts
Platelets, 02/23/09 Novel strategies for patients with chronic myeloproliferative disorders
Current Opinion in Hematology, 02/23/09 Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial
Leukemia, 02/23/09 The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies
British Journal of Haematology, 02/19/09 HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia
Journal of Clinical Oncology, 02/19/09
Evidence Based Medicine
Inhibition of eIF2 Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy
Cancer Research, 02/18/09 Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
Expert Review of Hematology, 02/17/09 Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes
Expert Review of Hematology, 02/17/09 Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
Journal of Clinical Oncology, 02/13/09 IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
British Journal of Haematology, 02/13/09 CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells
Blood, 02/12/09
Evidence Based Medicine
Inhibition of Aurora-kinases for tailored risk adapted treatment of multiple myeloma
Blood, 02/12/09
Evidence Based Medicine
The proteasome load vs. capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition
Blood, 02/12/09
Evidence Based Medicine
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
188 Available Pages
|
|
